Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Mersana Therapeutics, Inc. - Common Stock (NQ:MRSN)

29.07 -0.03 (-0.09%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 26, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 82,367
Open 29.10
Bid (Size) 28.65 (2,000)
Ask (Size) 29.55 (100)
Prev. Close 29.10
Today's Range 28.91 - 29.15
52wk Range 5.210 - 40.25
Shares Outstanding 71,761,525
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Alexander & Baldwin, Inc. (NYSE - ALEX), United Security Bancshares (Nasdaq - UBFO), Udemy, Inc. (Nasdaq - UDMY), Mersana Therapeutics, Inc. (Nasdaq - MRSN)
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
Halper Sadeh LLC Encourages MRSN, CSGS, RYI, GDOT Shareholders to Contact the Firm to Discuss Their Rights
Shareholders should contact the firm immediately as there may be limited time to enforce your rights 
From Halper Sadeh LLC
Via GlobeNewswire

Performance

YTD
-16.9%
-16.9%
1 Month
+6.1%
+6.1%
3 Month
+305.5%
+305.5%
6 Month
+257.8%
+257.8%
1 Year
-18.1%
-18.1%

More News

Read More
News headline image
Halper Sadeh LLC Encourages FFWM, MRSN, FSUN Shareholders to Contact the Firm to Discuss Their Rights
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
Halper Sadeh LLC Encourages CADE, MRSN, CDTX Shareholders to Contact the Firm to Discuss Their Rights
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Mersana Therapeutics, Inc. (Nasdaq - MRSN), Cidara Therapeutics, Inc. (Nasdaq - CDTX), Cadence Bank (NYSE – CADE)
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
Halper Sadeh LLC Encourages MRSN, CDTX, RYI Shareholders to Contact the Firm to Discuss Their Rights
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
Halper Sadeh LLC Encourages SEE, EXAS, MRSN Shareholders to Contact the Firm to Discuss Their Rights
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
Mersana Therapeutics Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Mersana Therapeutics, Inc. - MRSN
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Cidara Therapeutics, Inc. (Nasdaq - CDTX), Mersana Therapeutics, Inc. (Nasdaq - MRSN), TreeHouse Foods Inc. (NYSE - THS), Gulf Island Inc. (Nasdaq - GIFI)
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
Mersana Therapeutics Inc (NASDAQ:MRSN) Reports Mixed Q3 2025 Results Amid Acquisition News ↗
Via Chartmill
News headline image
Halper Sadeh LLC Encourages MRSN, THS, HBAN Shareholders to Contact the Firm to Discuss Their Rights
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
Earnings Scheduled For November 14, 2025 ↗
Via Benzinga
News headline image
Mersana Therapeutics Stock Explodes Over 200% To Notch Best Day Ever As $285M Buyout Trumps Analyst Downgrades: Retail Cheers ‘Very Good Bargain’ ↗
Via Stocktwits
News headline image
Stay updated with the stocks that are on the move in today's after-hours session. ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
Via Benzinga
News headline image
Dow Dips Over 400 Points; JD.com Posts Upbeat Q3 Results ↗
Via Benzinga
Topics Stocks
News headline image
Mersana Therapeutics Earnings Preview ↗
Via Benzinga
News headline image
Day One Biopharma Expands Oncology Pipeline With $285 Million Mersana Buyout ↗
Via Benzinga
News headline image
Nasdaq Down Over 150 Points; Disney Shares Fall After Q4 Results ↗
Via Benzinga
News headline image
Mersana Catapults 200% On Day One Bio's Surprise Buyout ↗
Via Investor's Business Daily
News headline image
MRSN Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Mersana Therapeutics, Inc. is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
Via Benzinga
News headline image
MRSN Stock Soars Over 200% Pre-Market After Day One Acquisition Deal ↗
Via Stocktwits
News headline image
Mersana Misses Fiscal Q2 Revenue Target ↗
Via The Motley Fool
News headline image
Earnings Scheduled For August 13, 2025 ↗
Via Benzinga

Frequently Asked Questions

Is Mersana Therapeutics, Inc. - Common Stock publicly traded?
Yes, Mersana Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Mersana Therapeutics, Inc. - Common Stock trade on?
Mersana Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Mersana Therapeutics, Inc. - Common Stock?
The ticker symbol for Mersana Therapeutics, Inc. - Common Stock is MRSN on the Nasdaq Stock Market
What is the current price of Mersana Therapeutics, Inc. - Common Stock?
The current price of Mersana Therapeutics, Inc. - Common Stock is 29.07
When was Mersana Therapeutics, Inc. - Common Stock last traded?
The last trade of Mersana Therapeutics, Inc. - Common Stock was at 12/26/25 04:00 PM ET
What is the market capitalization of Mersana Therapeutics, Inc. - Common Stock?
The market capitalization of Mersana Therapeutics, Inc. - Common Stock is 2.09B
How many shares of Mersana Therapeutics, Inc. - Common Stock are outstanding?
Mersana Therapeutics, Inc. - Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.